Mizuho Maintains Buy on Axsome Therapeutics, Raises Price Target to $109

Axsome Therapeutics, Inc. +1.61%

Axsome Therapeutics, Inc.

AXSM

76.39

+1.61%

Mizuho analyst Graig Suvannavejh maintains Axsome Therapeutics (NASDAQ: AXSM) with a Buy and raises the price target from $108 to $109.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via